Advertisement
BD Biosciences
BD Biosciences

H5N1 Researcher to Defy Dutch Gov’t?

A virologist at the center of avian flu research controversy says he’ll publish without government permits.

By | April 18, 2012

image: H5N1 Researcher to Defy Dutch Gov’t? Two avian influenza A (H5N1) virionsWikimedia Commons, Cynthia Goldsmith/Jackie Katz

Two avian influenza A (H5N1) virionsWIKIMEDIA COMMONS, CYNTHIA GOLDSMITH/JACKIE KATZ

Ron Fouchier of Erasmus Medical Center in the Netherlands, who last September announced the creation of a mutant version of the H5N1 avian flu virus transmissible between ferrets, says that he is prepared to defy the Dutch government’s export controls that have prevented him from submitting his work for publication, according to Nature.

Earlier this month, a US biosecurity panel recommended the full publication of the his group’s paper, as well as similar research out of the University of Wisconsin, Madison—contrary to the board’s original findings last December that some of the results should be redacted. But even with the US government’s okay, Fouchier has recently complained that the Dutch government’s export laws are standing in the way. Now Fouchier says that he is prepared to defy the government and submit the work anyway, an action that could cost him up to 6 years in prison or a $102,000 fine.

A spokesman for the Dutch Ministry of Economic Affairs, Agriculture, and Innovation told Nature that the government has not yet received an application from the Erasmus Medical Center for an export permit for the paper. The Dutch government plans to meet next week (April 23) to assess the risks and benefits of publishing the research. But even if they do insist on a permit, Fouchier says he will still publish.

“We simply will never apply for an export permit on a scientific manuscript for publication in a journal. We do not want to create a precedent here,” he told Nature. “We might end up in court indeed if they insist on censorship.”

For more on the debate of whether or not to publish these controversial studies, see our April 2012 feature, Deliberating Over Danger.”

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Pablo Fuentes-Prior

Pablo Fuentes-Prior

Posts: 1457

April 18, 2012

Egomaniac plays (science) hero. Disgusting.

Avatar of:

Posts: 0

April 18, 2012

Egomaniac plays (science) hero. Disgusting.

Avatar of:

Posts: 0

April 19, 2012

Export permit to publish something?  Really?  A complete misapplication of laws to material that should not be subject to them.

Avatar of: Ed Rybicki

Ed Rybicki

Posts: 82

April 19, 2012

Export permit to publish something?  Really?  A complete misapplication of laws to material that should not be subject to them.

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
INTEGRA
INTEGRA
Advertisement
Life Technologies